milliporesigma videos

  1. MilliporeSigma Bio-Expo Live February 2025: Downstream Bioprocessing 3/17/2025

    Advancements in single-use technologies are transforming antibody-drug conjugate manufacturing and offering increased flexibility. Examine key data, design considerations, operational benefits, and applications in ADC production.

  2. Master mRNA Manufacturing, Purification, And Plasmid DNA Processes 3/12/2025

    Whether you're a pro or a beginner, revolutionize your process and achieve excellence today by enhancing your mRNA manufacturing skills with valuable insights and tools.

  3. Master Your mRNA Manufacturing 3/4/2025

    Join pDNA and mRNA specialists as they discuss innovative mRNA manufacturing solutions for your purification challenges, mRNA stability, and overall product quality.

  4. Streamline Your mRNA Purification Steps 3/4/2025

    Ensure your mRNA's stability and effectiveness post-transcription with advanced filtration and chromatography techniques to enhance purity and recovery, which delivers high-quality mRNA for superior therapeutics and vaccines.

  5. Empowering Your Plasmid DNA Workflow 3/4/2025

    Unlock the full potential of your pDNA purification with advanced chromatography solutions and resins that tackle high viscosity and impurities to ensure superior quality and yield.

  6. Your Roadmap For Efficient Processes 3/4/2025

    Struggling with mRNA integrity? Discover essential strategies to boost stability in mRNA manufacturing with innovative endonuclease-free DTT and Spermidine chemicals.

  7. MilliporeSigma Accepts Its 2024 CDMO Leadership Award 7/18/2024

    From the March 2024 CDMO Leadership Awards celebration in Manhattan, hear from Matthias Bucerius, Head of Synthesis & ADC CDMO, as he accepts the award on behalf of MilliporeSigma.

  8. MilliporeSigma Capacity Update May 2024: Cell & Gene Therapy 6/13/2024

    Discover how we apply our 30 years of experience to enhance quality and de-risk viral vector production at any stage and knowhow to advance cell and gene therapies from pre-IND through routine supply.

  9. Bringing Your mRNA-Based Drug From Pre-Clinical To Commercial 5/24/2024

    Watch to explore how you can speed up your mRNA-based drug projects, reduce risks, and shorten time to market with comprehensive and seamless processes from pre-clinical development to commercialization.

  10. US GMP (21 CFR 820) Manufactured Oligos For Preclinical Research 10/18/2023

    Learn why Custom cGMP Oligos should be considered to ensure oligo products meet the strict standards of MDx, LDTs, and preclinical research.